ProSomnus Sleep Technologies, maker of ProSomnus [IA] and ProSomnus MicrO2 Sleep and Snore Devices, received FDA clearance in November 2016 for using the DentiTrac Compliance Sensor, which tracks when a patient is wearing his or her oral appliance. The company has now completed a controlled launch and is prepared to offer this compliance tracking technology to its customers.

Unlike manual cold cured acrylic manufacturing, the milled pocket in the control-cured polymethylmethacrylate (PMMA) material provides a more stable environment and puts less stress on the sensor, according to ProSomnus.

“The recorder can be downloaded monthly and keeps the data for 6 months. The report is easy to read and is similar to a CPAP download,” says Erika Mason, DDS, Diplomate ABDSM and ACSDD, in a release. “In time, I think, we will be able to utilize this for verifying CDL [commercial driver’s license] licensure as well as for pilots and other Department of Transportation verification standards. This appliance with the sensor, is smaller, so it is easier for patients to get used to it.”

Len Liptak, CEO of ProSomnus Sleep Technologies, says, “As recent scientific and clinical reports have demonstrated, compliance is an essential ingredient for effective therapy. The ProSomnus [IA] Sleep and Snore Device with the DentiTrac Compliance Tracking Sensor now offers dentists, and their extended treatment team, an option for objectively measuring compliance with oral appliance therapy.”

Lead faculty for clinical education, Mark T. Murphy, DDS, says, “The lack of objective compliance data has been a frequent complaint of physicians. Two papers presented at the AADSM demonstrated 89% compliance and over 7 hours per night! Not only should that help with acceptance of OAT, the mean disease alleviation should be much better than CPAP as well. And one of them was a physician! What and exciting time for dental sleep medicine.”

ProSomnus Sleep Technologies is a member of HealthpointCapital’s portfolio of investments.